Abstract
This study aimed to establish the level of awareness of hospital pharmacists towards management of patients on rivaroxaban in Saudi Arabia. A cross sectional study was conducted using self-administered questionnaire among hospital pharmacists, including clinical pharmacists, consultants, residents, and intern students at a tertiary hospital. A total of 116 pharmacists responded to the study, among the responses 93 (80.17%) were either inpatient or outpatient pharmacists. Although almost all respondents 88 (76%) correctly identified that rivaroxaban shown effective anticoagulant effect as convectional therapy with warfarin, there was a significant difference in knowledge of hemostatic agents (p < 0.001) as well as safe use of rivaroxaban before invasive procedures (p < 0.04) that might lead significant patient harm. The results of our cross sectional survey demonstrate that there is A gap in knowledge between pharmacists in awareness of hemostatic agents and counseling. Further studies should focus on raising pharmacists' knowledge about all direct oral anticoagulants (DOACs).